Journal ArticleDOI
The Value of PSA Density in Combination with PI-RADS™ for the Accuracy of Prostate Cancer Prediction
Florian Distler,Jan Philipp Radtke,Jan Philipp Radtke,David Bonekamp,Claudia Kesch,Heinz Peter Schlemmer,Kathrin Wieczorek,Marietta Kirchner,Sascha Pahernik,Markus Hohenfellner,Boris Hadaschik +10 more
TLDR
Using prostate specific antigen density combined with multiparametric magnetic resonance imaging improved the negative predictive value of PI‐RADS scoring, which means approximately 20% of unnecessary biopsies could be avoided safely.About:
This article is published in The Journal of Urology.The article was published on 2017-09-01. It has received 176 citations till now. The article focuses on the topics: PI-RADS & Prostate cancer.read more
Citations
More filters
Journal ArticleDOI
Prostate MRI, with or without MRI‐targeted biopsy, and systematic biopsy for detecting prostate cancer
Frankâ€Jan H Drost,Daniël F Osses,Daan Nieboer,Ewout W. Steyerberg,Chris H. Bangma,Monique J. Roobol,Ivo G. Schoots +6 more
TL;DR: The diagnostic accuracy of the index tests MRI only, MRI-targeted biopsy, the MRI pathway and systematic biopsy as compared to template-guidedBiopsy as the reference standard in detecting clinically significant prostate cancer as the target condition was determined.
Journal ArticleDOI
Multiparametric MRI for prostate cancer diagnosis: current status and future directions
Armando Stabile,Armando Stabile,Armando Stabile,Francesco Giganti,Francesco Giganti,Andrew B. Rosenkrantz,Samir S. Taneja,Geert Villeirs,Inderbir S. Gill,Clare Allen,Mark Emberton,Mark Emberton,Caroline M. Moore,Caroline M. Moore,Veeru Kasivisvanathan,Veeru Kasivisvanathan +15 more
TL;DR: Improvements in inter-reader agreement, development of computer-aided diagnostic systems and assessment of biomarkers to use in combination with mpMRI are needed.
Journal ArticleDOI
PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway.
Anwar R. Padhani,Jelle O. Barentsz,Geert Villeirs,Andrew B. Rosenkrantz,Daniel Margolis,Baris Turkbey,Harriet C. Thoeny,François Cornud,Masoom A. Haider,Katarzyna J. Macura,Clare M. Tempany,Sadhna Verma,Jeffrey C. Weinreb +12 more
TL;DR: The PI-RADS Steering Committee discusses how the MRI pathway should be incorporated into routine clinical practice and the challenges in delivering the positive health impacts needed by men suspected of having clinically significant prostate cancer.
Journal ArticleDOI
Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review and Meta-analysis.
Veeru Kasivisvanathan,Armando Stabile,Armando Stabile,Joana B. Neves,Francesco Giganti,Francesco Giganti,Massimo Valerio,Yaalini Shanmugabavan,Keiran D. Clement,Debashis Sarkar,Yiannis Philippou,David Thurtle,Jonathan J Deeks,Jonathan J Deeks,Mark Emberton,Mark Emberton,Yemisi Takwoingi,Yemisi Takwoingi,Caroline M. Moore +18 more
TL;DR: MRI-TB is an attractive alternative diagnostic strategy to systematic biopsy for diagnosing prostate cancer and biopsies targeted to suspicious areas on magnetic resonance imaging were better at detecting prostate cancer that needs to be treated and avoiding the diagnosis of disease that does not need treatment.
Journal ArticleDOI
Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer
TL;DR: PSA-density might inform biopsy decisions, and spare some men from the morbidity associated with a prostate biopsy and diagnosis of low-grade prostate cancer.
References
More filters
Journal ArticleDOI
The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma
Geert J.L.H. van Leenders,Theodorus van der Kwast,David J. Grignon,Andrew Evans,Glen Kristiansen,Charlotte F. Kweldam,Geert Litjens,Jesse K. McKenney,Jonathan Melamed,N. Mottet,Gladell P. Paner,Hemamali Samaratunga,Ivo G. Schoots,Jeffry P. Simko,Toyonori Tsuzuki,Murali Varma,Anne Y. Warren,Thomas M. Wheeler,Sean R. Williamson,Kenneth A. Iczkowski +19 more
TL;DR: This manuscript summarizes the proceedings of the ISUP consensus meeting for grading of prostatic carcinoma held in September 2019, in Nice, France, where topics brought to consensus included approaches to reporting of Gleason patterns 4 and 5 quantities, and minor/tertiary patterns.
Journal ArticleDOI
PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2
Jeffrey C. Weinreb,Jelle O. Barentsz,Peter L. Choyke,François Cornud,Masoom A. Haider,Katarzyna J. Macura,Daniel Margolis,Mitchell D. Schnall,Faina Shtern,Clare M. Tempany,Harriet C. Thoeny,Sadna Verma +11 more
TL;DR: The Prostate Imaging - Reporting and Data System Version 2 (PI-RADS™ v2) simplifies and standardizes terminology and content of reports, and provides assessment categories that summarize levels of suspicion or risk of clinically significant prostate cancer that can be used to assist selection of patients for biopsies and management.
Journal ArticleDOI
ESUR prostate MR guidelines 2012
Jelle O. Barentsz,Jonathan Richenberg,R. Clements,Peter L. Choyke,Sadhna Verma,Geert Villeirs,Olivier Rouvière,Vibeke Løgager,Jurgen J. Fütterer +8 more
TL;DR: Clinical indications, and minimal and optimal imaging acquisition protocols are provided, and a structured reporting system (PI-RADS) is described.
Journal ArticleDOI
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
Hashim U. Ahmed,Hashim U. Ahmed,Ahmed El-Shater Bosaily,Ahmed El-Shater Bosaily,Louise Brown,Rhian Gabe,Richard Kaplan,Mahesh K.B. Parmar,Yolanda Collaco-Moraes,Katie Ward,Richard Hindley,Alex Freeman,Alex Kirkham,Robert Oldroyd,Chris Parker,Mark Emberton,Mark Emberton +16 more
TL;DR: Using MP-MRI to triage men might allow 27% of patients avoid a primary biopsy and diagnosis of 5% fewer clinically insignificant cancers, as well as reduce unnecessary biopsies by a quarter.
Journal ArticleDOI
Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer
TL;DR: Serum PSA level, PSA density, and needle biopsy pathologic findings are accurate predictors of tumor extent and it may be reasonable to follow up some patients whose tumors are most likely insignificant with serial PSA measurements and repeated biopsies.
Related Papers (5)
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
Veeru Kasivisvanathan,Antti Rannikko,Marcelo Borghi,Valeria Panebianco,Lance A. Mynderse,Markku H. Vaarala,Alberto Briganti,Lars Budäus,Giles Hellawell,Richard G. Hindley,Monique J. Roobol,Scott E. Eggener,Maneesh Ghei,Arnauld Villers,Franck Bladou,Geert M. Villeirs,Jaspal Virdi,S. Boxler,Grégoire Robert,Paras B. Singh,Wulphert Venderink,Boris Hadaschik,Alain Ruffion,Jim C. Hu,Daniel Margolis,Sebastien Crouzet,Laurence Klotz,Samir S. Taneja,Peter A. Pinto,Inderbir S. Gill,Clare Allen,Francesco Giganti,Alex Freeman,Stephen Morris,Shonit Punwani,Norman R. Williams,Chris Brew-Graves,Jonathan J Deeks,Yemisi Takwoingi,Mark Emberton,Caroline M. Moore +40 more